Education
About Us
Working with TipRanks
Follow Us
Lantheus (LNTH)
NASDAQ:LNTH
LNTH Stock Chart & Stats
Day’s Range― - ―
52-Week Range$57.92 - $126.89
Previous CloseN/A
Volume177.90K
Average Volume (3M)1.02M
Market Cap
$6.69B
Enterprise Value$7.77B
Total Cash (Recent Filing)$912.81M
Total Debt (Recent Filing)$974.00K
Price to Earnings (P/E)22.3
Beta0.21
Next Earnings
May 01, 2025EPS Estimate
1.64Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)4.37
Shares Outstanding68,476,580
10 Day Avg. Volume862,797
30 Day Avg. Volume1,021,189
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)N/A
Price to Sales (P/S)4.36
Price to Cash Flow (P/CF)10.60
P/FCF Ratio6.50
Enterprise Value/Market Cap1.16
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit7.87
Enterprise Value/Ebitda15.09
Forecast
1Y Price Target
$127.13Price Target Upside30.11% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering9
---
Lantheus News
PremiumCompany Announcements
Lantheus Holdings Inc. Reports Strong Growth and Strategic Moves
PremiumCompany Announcements
Lantheus Holdings Faces Uncertainty Amid Potential PET Scanner Shortage
PremiumCompany Announcements
Lantheus Holdings Reports Strong 2024 Financial Performance---
Bulls Say, Bears Say
Bulls Say
Market ExpansionThe upward revision of the PSMA PET total addressable market to $3.5 billion by 2030 indicates continued share gains from bone CT scans.
Revenue Performance4Q24 total revenue of $391.1M beat consensus of $376.2M and estimate of $370.2M.
Strategic GrowthLantheus' recent strategic acquisitions of Life Molecular Imaging and Evergreen Theragnostics position the company well for future growth.
Bears Say
Earnings ForecastThe updated earnings per share for the full year 2025 are lower than previous estimates.
Revenue GuidanceFY25 total revenue guidance was slightly below consensus expectations.
---
Ownership Overview
2.11% Insiders
37.42% Mutual Funds
2.45% Other Institutional Investors
31.37% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
LNTH FAQ
What was Lantheus’s price range in the past 12 months?
Lantheus lowest stock price was $57.92 and its highest was $126.89 in the past 12 months.
What is Lantheus’s market cap?
Lantheus’s market cap is $6.69B.
When is Lantheus’s upcoming earnings report date?
Lantheus’s upcoming earnings report date is May 01, 2025 which is in 37 days.
How were Lantheus’s earnings last quarter?
Lantheus released its earnings results on Feb 26, 2025. The company reported $1.59 earnings per share for the quarter, beating the consensus estimate of $1.543 by $0.047.
Is Lantheus overvalued?
According to Wall Street analysts Lantheus’s price is currently Undervalued.
Does Lantheus pay dividends?
Lantheus does not currently pay dividends.
What is Lantheus’s EPS estimate?
Lantheus’s EPS estimate is 1.64.
How many shares outstanding does Lantheus have?
Lantheus has 68,476,580 shares outstanding.
What happened to Lantheus’s price movement after its last earnings report?
Lantheus reported an EPS of $1.59 in its last earnings report, beating expectations of $1.543. Following the earnings report the stock price went up 16.49%.
Which hedge fund is a major shareholder of Lantheus?
Currently, no hedge funds are holding shares in LNTH
---
Lantheus Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$127.13 (30.11% Upside)
$127.13 (30.11% Upside)
Blogger Sentiment
Bullish
LNTH Sentiment 100%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 2.2M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $281.5 over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.6%
Last 30 Days ▼ 7.0%
Last 30 Days ▼ 7.0%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
66.39%
12-Months-Change
Fundamentals
Return on Equity
32.82%
Trailing 12-Months
Asset Growth
22.04%
Trailing 12-Months
Company Description
Lantheus
Lantheus Holdings, Inc. engages in the development, manufacture and commercialization of diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its products are used by cardiologists, nuclear physicians, radiologists, internal medicine physicians, sonographers and technologists working in a variety of clinical settings. The firm operates through the following geographical segments: U.S. and International. The U.S. segment produces and markets medical imaging agents and products throughout the U.S. This segment sells its products to radio pharmacies, integrated delivery networks, hospitals, clinics and group practices. The International segment operations consist of production and distribution activities in Puerto Rico and direct distribution activities in Canada. The company was founded in 1956 and is headquartered in North Billerica, MA.
---
LNTH Company Deck
---
LNTH Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Lantheus reported strong revenue growth driven by Pylarify and DEFINITY, alongside strategic acquisitions expected to bolster future growth. However, challenges include increased operating expenses and a net loss for the quarter. Despite these challenges, the company remains optimistic about its pipeline and strategic direction.Read More>---
LNTH Revenue Breakdown
65.91% Radiopharmaceutical oncology
30.09% Precision diagnostics
4.00% Strategic Partnerships and other revenue
---
LNTH Stock 12 Month Forecast
Average Price Target
$127.13
▲(30.11% Upside)
Technical Analysis
Best Analysts Covering LNTH
1 Year
1 Year Success Rate
22/30 ratings generated profit
1 Year Average Return
+51.88%
reiterated a buy rating 27 days ago
Copying Richard Newitter's trades and holding each position for 1 Year would result in 73.33% of your transactions generating a profit, with an average return of +51.88% per trade.
---